Building up others: Neuro-oncology social worker Jennifer St. Clair helps patients from bedside to finish line
Jennifer St. Clair's major achievements include organizing and launching the Cancer Chomp 5K event.
Posts tagged as
Duane Mitchell
UF-developed mRNA vaccine featured in The Economist
An article in The Economist highlights how cancer vaccines are showing promise.
Remembering Harris Rosen: A life of impact
Harris Rosen gave $12 million in 2019 to advance innovative brain tumor immunotherapy research and care at UF Health. He passed away in November.
Research Snapshot: Gene therapy method may enhance effectiveness of immunotherapy treatments in glioblastoma
The promising strategy could be used in combination with other treatments to increase the effectiveness of glioblastoma therapies.
UF researchers to test novel treatments for medulloblastoma
The Phase I trials to treat medulloblastoma will be led by Duane Mitchell, M.D., Ph.D., and Elias Sayour, M.D., Ph.D.
UF Health Cancer Center researchers in the news: mRNA cancer vaccine in glioblastoma
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.
UF-developed mRNA vaccine triggers fierce immune response to fight malignant brain tumor
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.
Duane Mitchell, M.D., Ph.D., honored with inaugural Louis W. Sullivan, M.D., Award
Duane Mitchell, M.D., Ph.D., was honored by the American Society for Clinical Investigation for his work on immunotherapy treatments for brain cancer.
Duane Mitchell, M.D., Ph.D., appointed co-chair of CTSA program steering committee
Duane Mitchell, M.D., Ph.D., associate director for translation and innovation, has been appointed co-chair of the CTSA Program Steering Committee.
UF brain tumor team featured on ESPN
ESPN and ABC aired videos highlighting UF Health’s efforts to fight brain cancer.
